chartexchange

CAPR Stock Rallies After-Hours As Capricor Reaffirms Deramiocel Confidence Ahead Of Nov. 22 Decision; Says Application In Final Review

Stocktwits | Nov 10, 2026 6:56 PM EST

The U.S. Food and Drug Administration is slated to decide on approving Deramiocel for the treatment of DMD by November 22.

Read original article